FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1235.228

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1235.228
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.228/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228
Version20230118
Statusactive
Date2023-01-18T01:03:05-05:00
NameInfluenzaVaccineCN_HD_SNOMED
TitleInfluenza Vaccine CN_HD_SNOMED
Realmus
Authorityhl7
Descriptionb.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need.
Purpose(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1235.232Influenza Vaccine_HD_CN_Grouping

Resources that this resource uses

CodeSystem
sctSNOMED CT (all versions)

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.228",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "B.well Connected Health Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-06-04"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-01-18"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1235.228"
    }
  ],
  "version": "20230118",
  "name": "InfluenzaVaccineCN_HD_SNOMED",
  "title": "Influenza Vaccine CN_HD_SNOMED",
  "status": "active",
  "date": "2023-01-18T01:03:05-05:00",
  "publisher": "B.well Connected Health Steward",
  "description": "b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "127787002",
            "display": "Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code": "16292241000119109",
            "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type B capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure)"
          },
          {
            "code": "170343007",
            "display": "Administration of first dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code": "170344001",
            "display": "Administration of second dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code": "170345000",
            "display": "Administration of third dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code": "170346004",
            "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type B antigen (procedure)"
          },
          {
            "code": "310306005",
            "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code": "310307001",
            "display": "Administration of second dose of Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code": "310308006",
            "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code": "312869001",
            "display": "Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code": "312870000",
            "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (procedure)"
          },
          {
            "code": "346524008",
            "display": "Influenza split virion vaccine (product)"
          },
          {
            "code": "346525009",
            "display": "Inactivated Influenza surface antigen sub-unit vaccine (product)"
          },
          {
            "code": "348046004",
            "display": "Influenza (split virion) vaccine injection suspension 0.5mL prefilled syringe (product)"
          },
          {
            "code": "348047008",
            "display": "Inactivated Influenza surface antigen sub-unit vaccine prefilled syringe (product)"
          },
          {
            "code": "391668002",
            "display": "Inactivated Influenza vaccine (split virion) prefilled syringe 0.5mL (product)"
          },
          {
            "code": "391669005",
            "display": "Inactivated Influenza vaccine (surface antigen) prefilled syringe 0.5mL (product)"
          },
          {
            "code": "400564003",
            "display": "Influenza virus vaccine trivalent 45mcg/0.5mL injection solution 5mL vial (product)"
          },
          {
            "code": "400788004",
            "display": "Influenza virus vaccine triv 45mcg/0.5mL injection solution 0.5mL syringe (product)"
          },
          {
            "code": "408752008",
            "display": "Inactivated influenza split virion vaccine (product)"
          },
          {
            "code": "414001002",
            "display": "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "414259000",
            "display": "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "415507003",
            "display": "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "415712004",
            "display": "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure)"
          },
          {
            "code": "418707004",
            "display": "Inactivated Influenza surface antigen virosome vaccine prefilled syringe (product)"
          },
          {
            "code": "419562000",
            "display": "Inactivated Influenza surface antigen virosome vaccine (product)"
          },
          {
            "code": "429914001",
            "display": "Inactivated influenza split virus trivalent vaccine 0.5mL vial (product)"
          },
          {
            "code": "430410002",
            "display": "Product containing Influenza virus vaccine in nasal dose form (medicinal product form)"
          },
          {
            "code": "430482001",
            "display": "Inactivated influenza split virus trivalent vaccine 0.25mL prefilled syringe (product)"
          },
          {
            "code": "430620004",
            "display": "Inactivated influenza split virus trivalent vaccine 0.5mL prefilled syringe (product)"
          },
          {
            "code": "46233009",
            "display": "Influenza virus vaccine (product)"
          },
          {
            "code": "770608009",
            "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "770616000",
            "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "770617009",
            "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "770618004",
            "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "786846001",
            "display": "Administration of vaccine product containing only Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
          },
          {
            "code": "786847005",
            "display": "Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"
          },
          {
            "code": "787016008",
            "display": "Administration of vaccine product containing only Influenza virus antigen in nasal dose form (procedure)"
          },
          {
            "code": "787436003",
            "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (procedure)"
          },
          {
            "code": "787438002",
            "display": "Vaccination for diphtheria, pertussis, tetanus, poliomyelitis, Hepatitis B virus and Haemophilus influenzae type b (procedure)"
          },
          {
            "code": "86198006",
            "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:c1cad070-0833-49a2-89bb-c9dc6efd4d72",
    "timestamp": "2025-05-23T20:20:28-04:00",
    "total": 24,
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "127787002",
        "display": "Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "16292241000119109",
        "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170343007",
        "display": "Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170344001",
        "display": "Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170345000",
        "display": "Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170346004",
        "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "310306005",
        "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "310307001",
        "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "310308006",
        "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "312869001",
        "display": "Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "312870000",
        "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "414001002",
        "display": "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "414259000",
        "display": "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "415507003",
        "display": "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "415712004",
        "display": "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "770608009",
        "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "770616000",
        "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "770617009",
        "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "770618004",
        "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "786846001",
        "display": "Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "786847005",
        "display": "Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "787016008",
        "display": "Administration of vaccine product containing only Influenza virus antigen in nasal dose form (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "787436003",
        "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "86198006",
        "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
      }
    ]
  }
}